Skip to content

Insider · CIK 0002005448

Christina Rizopoulos Valauri

director

Files at PRPO (Precipio, Inc.), VBIO (Valion Bio, Inc.). First filing Apr 2, 2026, latest Apr 2, 2026.

Christina Rizopoulos Valauri files SEC Form 4 as director at VBIO (Valion Bio, Inc.), and also at PRPO (Precipio, Inc.). Since Apr 2, 2026, Christina Rizopoulos Valauri has reported 1 open-market buy worth $18k and 0 open-market sells worth $0, the latest filed on Apr 2, 2026.

A track record needs three past buys with six months of prices behind them; Christina Rizopoulos Valauri has 0, so none is measured yet.

The newest scored trade: bought $18k of VBIO on Apr 1, 2026, filed Apr 2, 2026, scored 31 (weak). In the last 12 months: 1 buy worth $18k and 0 sells worth $0.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$18k bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
31Weak
VBIObuy 2
Valion Bio, Inc.
$18k
19,000 shares
--

Transactions

Every row this insider has filed, 7 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Apr 15, 2026PRPO
Precipio, Inc.
AGrant or award
Common Stock
+93$29.49$2,7435,520Apr 17, 2026
Apr 1, 2026VBIO
Valion Bio, Inc.
POpen-market purchase
Common Stock
+19,000$0.95$18k19,000Apr 2, 2026
Jan 15, 2026PRPO
Precipio, Inc.
AGrant or award
Common Stock
+406$24.00$9,7445,427Jan 20, 2026
Jan 2, 2026PRPO
Precipio, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+1,500$0.00$01,500Jan 6, 2026
Aug 6, 2025VBIO
Valion Bio, Inc.
AGrant or award
Stock Option (Right to Purchase)derivative
+7,500$0.00$07,500Aug 8, 2025
Dec 18, 2024VBIO
Valion Bio, Inc.
AGrant or award
Stock Option (Right to Purchase)derivative
+12,000$0.00$012,000Dec 20, 2024
Oct 15, 2024PRPO
Precipio, Inc.
AGrant or award
Common Stock
+1,472$6.62$9,7455,021Oct 17, 2024

Questions about Christina Rizopoulos Valauri

Answered from the filings on this page, as of the latest one.

Is Christina Rizopoulos Valauri buying or selling?

In the last 12 months Christina Rizopoulos Valauri reported 1 open-market buy worth $18k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $18k of VBIO on Apr 1, 2026. Grants, option exercises and tax withholding are not counted.

How did Christina Rizopoulos Valauri's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christina Rizopoulos Valauri has 0.

Where does Christina Rizopoulos Valauri file Form 4?

Christina Rizopoulos Valauri has filed Form 4 at VBIO (Valion Bio, Inc.); PRPO (Precipio, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.